Company / FCF Margin
Actinium Pharmaceuticals, Inc. FCF Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-27426.7%
FY2025
5-year range
-58627.2% / 803.7%
FY2021-FY2025
Trend
+53.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from 803.7% to -27426.7% over the past 2 years.
Based on SEC 10-K filings.
-27426.7% in FY2025 with a 3-year CAGR of -25591.1%.
Declined from 803.7% to -27426.7% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -25591.1pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 53.2% year-over-year.
- Peak fcf margin was recorded in FY2023.
- Lowest fcf margin in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -27426.7% | +53.2% |
| FY2024 | -58627.2% | -7394.7% |
| FY2023 | 803.7% | +143.8% |
| FY2022 | -1835.6% | +4.0% |
| FY2021 | -1911.7% | - |
| FY2011 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026